Artiva Biotherapeutics CEO Aslan Fred sells $690K in shares
Aslan Fred, a director and Chief Executive Officer, sold 61,888 shares in an automatic sell-to-cover under a reported Form 4 filing. Weighted average sale price was $11.1555 per share, totaling $690,391.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.